About Us
Valo Health is a technology company that integrates human-centric data and AI-powered technology to accelerate the creation of life-changing drugs. Valo was created with the belief that the drug discovery and development process can and should be faster and less expensive, with a higher success rate. We use models early to fail less often as we reinvent drug discovery and development from the ground up. Disease doesn’t wait, so neither can we.
We are a multi-disciplinary team of experts in science, technology, and pharmaceuticals united in our mission to achieve better drugs for patients, faster. Valo is committed to hiring diverse talent, prioritizing growth and development, fostering an inclusive environment, and creating opportunities to bring together a group of different experiences, backgrounds, and voices to work together. We achieve the widest-ranging impact when we leverage our broad backgrounds and perspectives to accelerate a new frontier in health. Valo’s machine learning and AI capabilities are built on high-quality, high-density translational biology data from multiple sources: that’s where you come in!
About The Role
The Director, Program Management (PM) will work together with Therapeutics and Technology Program and Project Leads to ensure strategic and operational excellence across a portfolio of wholly owned and partnered target discovery programs and platform projects.
They will be accountable for planning, tracking, and reporting progress against key project artifacts, including goals, milestones, risks, budget, and resources, and share responsibility with the Program or Project Lead for driving operational excellence and alignment through crisp data-driven decision-making while maintaining a high-performing team environment.
What You'll Do...
What You Bring...
More on Valo
Valo Health, LLC (“Valo”) is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence-driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative diseases. Founded by Flagship Pioneering and headquartered in Lexington, MA, Valo also has offices in New York, NY. To learn more, visit www.valohealth.com.